William Hawkins

455 total citations
16 papers, 361 citations indexed

About

William Hawkins is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, William Hawkins has authored 16 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in William Hawkins's work include Virus-based gene therapy research (3 papers), CAR-T cell therapy research (3 papers) and Prostate Cancer Treatment and Research (3 papers). William Hawkins is often cited by papers focused on Virus-based gene therapy research (3 papers), CAR-T cell therapy research (3 papers) and Prostate Cancer Treatment and Research (3 papers). William Hawkins collaborates with scholars based in United States, Russia and Italy. William Hawkins's co-authors include Kristoffer Valerie, Rupert Schmidt‐Ullrich, Peck‐Sun Lin, Paul Dent, Guido Lammering, Ross B. Mikkelsen, F. Benetollo, A. Polo, L.M. Vallarino and Adly Yacoub and has published in prestigious journals such as Molecular Cell, Gastroenterology and JNCI Journal of the National Cancer Institute.

In The Last Decade

William Hawkins

16 papers receiving 354 citations

Peers

Countries citing papers authored by William Hawkins

Since Specialization

Citations

This map shows the geographic impact of William Hawkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Hawkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Hawkins more than expected).

Fields of papers citing papers by William Hawkins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Hawkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Hawkins. The network helps show where William Hawkins may publish in the future.

Co-authorship network of co-authors of William Hawkins

This figure shows the co-authorship network connecting the top 25 collaborators of William Hawkins. A scholar is included among the top collaborators of William Hawkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Hawkins. William Hawkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Chemical Perturbations Impacting Histone Acetylation Govern Colorectal Cancer Differentiation 2025 ·Gastroenterology ·(unknown), Zhixin Li, (unknown), Sándor Spisák, (unknown), Qi Liu, (unknown), (unknown), David J. Chen, (unknown), Pranshu Sahgal, (unknown), (unknown), Malvina Papanastasiou, William Hawkins, Steven A. Carr, Haeseong Park, James M. Cleary, Jun Qi, Nilay S. Sethi	1
2	An autoinhibitory switch of the LSD1 disordered region controls enhancer silencing 2024 ·Molecular Cell ·Amanda L. Waterbury, Hui Si Kwok, (unknown), (unknown), Allyson M. Freedy, (unknown), (unknown), (unknown), William Hawkins, Kwangwoon Lee, Jiaming Li, (unknown), Michael Vinyard, Philip A. Cole, Anders S. Hansen, Steven A. Carr, Malvina Papanastasiou, Brian B. Liau	13
3	Role of plasma membrane disruption in reference moist smokeless tobacco-induced cell death 2010 ·Toxicology Letters ·Andrew R. Joyce, William Hawkins, Marc W. Fariss, Tapas K. Sengupta	3
4	Transient exposure of carcinoma cells to RAS/MEK inhibitors and UCN-01 causes cell deathin vitroandin vivo 2008 ·Molecular Cancer Therapeutics ·Hossein A. Hamed, William Hawkins, Clint Mitchell, Donna Gilfor, Guo Zhang, Xin‐Yan Pei, Yun Dai, Michael P. Hagan, John D. Roberts, Adly Yacoub, Steven Grant, Paul Dent	17
5	Human chorionic gonadotropin (hCG) interacts with lovastatin and ionizing radiation to modulate prostate cancer cell viability in vivo 2008 ·Cancer Biology & Therapy ·Hossein A. Hamed, Clint Mitchell, Margaret A. Park, David E. Hanna, Aditi Pandya Martin, Benjamin S. Harrison, William Hawkins, (unknown), Paul B. Fisher, Steven Grant, Adly Yacoub, Michael P. Hagan, Paul Dent	2
6	MEK1/2 inhibition promotes Taxotere® lethality in mammary tumors in vivo 2006 ·Cancer Biology & Therapy ·Adly Yacoub, Donna Gilfor, William Hawkins, Margaret A. Park, David E. Hanna, Michael P. Hagan, David T. Curiel, Paul B. Fisher, Steven Grant, Paul Dent	9
7	Human Chorionic Gonadotropin Modulates Prostate Cancer Cell Survival after Irradiation or HMG CoA Reductase Inhibitor Treatment 2006 ·Molecular Pharmacology ·Adly Yacoub, William Hawkins, David E. Hanna, (unknown), Margaret A. Park, Mark Grant, John D. Roberts, David T. Curiel, Paul B. Fisher, Kristoffer Valerie, Steven Grant, Michael P. Hagan, Paul Dent	7
8	Transient exposure of mammary tumors to PD184352 and UCN-01 causes tumor cell death in vivo and prolonged suppression of tumor re-growth 2005 ·Cancer Biology & Therapy ·William Hawkins, Clint Mitchell, Robert McKinstry, Donna Gilfor, (unknown), Yun Dai, (unknown), Viswanathan Ramakrishnan, John D. Roberts, Adly Yacoub, Steven Grant, Paul Dent	16
9	Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival 2005 ·Molecular Cancer Therapeutics ·Rubén W. Carón, Adly Yacoub, Min Li, Xiaoyu Zhu, Clint Mitchell, Young Ki Hong, William Hawkins, Takehiko Sasazuki, Senji Shirasawa, Alan P. Kozikowski, Philip A. Dennis, Michael P. Hagan, Steven Grant, Paul Dent	62
10	Inhibition of the Type III Epidermal Growth Factor Receptor Variant Mutant Receptor by Dominant-Negative EGFR-CD533 Enhances Malignant Glioma Cell Radiosensitivity 2004 ·Clinical Cancer Research ·Guido Lammering, (unknown), (unknown), Kristoffer Valerie, William Hawkins, Peck‐Sun Lin, Ross B. Mikkelsen, Rupert Schmidt‐Ullrich	59
11	Radiosensitization of human glioma cells in vitro and in vivo with acyclovir and mutant HSV-TK75 expressed from adenovirus 2002 ·International Journal of Radiation OncologyBiologyPhysics ·Elizabeth Rosenberg, William Hawkins, Matthew Holmes, Cyrus Amir, Rupert Schmidt‐Ullrich, Peck-Sun Lin, Kristoffer Valerie	13
12	Epidermal Growth Factor Receptor as a Genetic Therapy Target for Carcinoma Cell Radiosensitization 2001 ·JNCI Journal of the National Cancer Institute ·Guido Lammering, (unknown), William Hawkins, Joseph N. Contessa, Dean B. Reardon, Peck‐Sun Lin, Kristoffer Valerie, Paul Dent, Ross B. Mikkelsen, Rupert Schmidt‐Ullrich	78
13	Substantially improved in vivo radiosensitization of rat glioma with mutant HSV-TK and acyclovir 2001 ·Cancer Gene Therapy ·Kristoffer Valerie, William Hawkins, Julie Farnsworth, Rupert Schmidt‐Ullrich, Peck‐Sun Lin, Cyrus Amir, Jeffrey Feden	23
14	EGFR and its mutant EGFRvIII as modulators of tumor cell radiosensitivity 2001 ·International Journal of Radiation OncologyBiologyPhysics ·Guido Lammering, (unknown), Joseph N. Contessa, William Hawkins, Peck‐Sun Lin, Kristoffer Valerie, Ross B. Mikkelsen, Paul Dent, Rupert Schmidt‐Ullrich	1
15	Synthesis, characterization, and x-ray crystal structure of tris-isothiocyanato complexes of the yttrium(III) and europium(III) ions with a six-nitrogen-donor macrocyclic ligand 1989 ·Polyhedron ·(unknown), F. Benetollo, A. Polo, Luisa De Cola, William Hawkins, L.M. Vallarino	35
16	Synthesis, characterization and X-ray crystal structure of yttrium(III) macrocyclic complexes with a six-nitrogen-donor cavity 1989 ·Polyhedron ·G. Bombieri, F. Benetollo, William Hawkins, A. Polo, L.M. Vallarino	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact